Homocysteine, a Biomarker of Cardiovascular Diseases, in Psoriasis–A Case Control Study
Journal: Clinical Dermatology Open Access Journal (CDOAJ) (Vol.4, No. 1)Publication Date: 2019-01-17
Authors : Garg P Gupta S Gupta N; Gupta N;
Page : 1-5
Keywords : Homocysteine; Psoriasis; Cardiovascular disease;
Abstract
For atherosclerotic and cardiovascular diseases, stroke and peripheral arterial disease, hyperhomocysteinemia has been seen to be an independent marker. Psoriasis being a chronic inflammatory disease is associated with increased incidence of cardiovascular events. Hyperhomocysteinemia in psoriasis plays an important role in these events. Our study aims to investigate serum homocysteine levels in patients of psoriasis. Thirty patients of different severity of psoriasis (calculated with body surface area (BSA) and Psoriasis Area and Severity Index (PASI) score) were investigated for serum levels of homocysteine. Thirty controls were also studied for the same investigations. Serum homocysteine levels were significantly higher in psoriasis patients compared to control group (p<0.05). This may explain the excess cardiovascular morbidity and mortality in psoriasis.
Other Latest Articles
- Betaine Potentials to Prevent Diabetes and Diabetic Complications: What Hindered the Favorable Clinical Trial Outcomes and What to do?
- Hailey-Hailey Disease with Nail Changes Preceding the Skin Changes- A Case Report
- Frequency of Metabolic Syndrome According to Optimal CutPoints for Body Mass Index in Saudi Population
- Leprosy and Eye Injuries
- Antibacterial Activity of Ginger (Zingiber Officinale Rosc.) Rhizome: A Mini Review
Last modified: 2019-03-23 19:43:58